Latest research
Latest corporate research
Latest tax enhanced reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact Us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax enhanced research
Product reports for investors and advisors
Latest published research
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Services for private Companies
Tax enhanced research
Product reports for investors and advisors.
Bespoke consulting services
Bespoke services
Services for clients with specific needs
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
24: Making big ideas investible and measuring impact | Dan Somers of Boundary Capital
Stay up-to-date with the latest research
Sign up to our newsletter
COVID-19: -
Our Commitment to Client Service & Investor Communications
Life Sciences research
Allergy Therapeutics plc
Life Sciences
Opening the door to registration
By
Dr Martin Hall
21 May 2018
Redx Pharma
Life Sciences
Clinical and corporate update
By
Dr Martin Hall
15 May 2018
Stay up-to-date with the latest research
Sign up to our newsletter
Alliance Pharma Plc
Life Sciences
Entering the US market
By
Dr Martin Hall
19 Apr 2018
Avacta Group plc
Life Sciences
Commendable rate of progress
By
Dr Martin Hall
17 Apr 2018
genedrive Plc
Life Sciences
Progressing commercialisation plans
By
Dr Martin Hall
12 Apr 2018
Life Sciences
Global Pharmaceuticals: 2017 industry statistics
By
Dr Martin Hall
11 Apr 2018
Tissue Regenix
Life Sciences
CellRight hits the right note
By
Dr Dorothea Hill
05 Apr 2018
Allergy Therapeutics plc
Life Sciences
Progressive development across portfolio
By
Dr Martin Hall
05 Apr 2018
Diurnal Group Plc
Life Sciences
Capital increase to support commercial plans
By
Dr Martin Hall
21 Mar 2018
Oxford BioMedica
Life Sciences
Supply to meet demand
By
Dr Dorothea Hill
20 Mar 2018
Advanced Oncotherapy
Life Sciences
Confidence greatly boosted
By
Dr Martin Hall
12 Mar 2018
Prev
1
...
9
10
11
12
13
...
17
Next
